This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmaceutical agents. Its trifluoromethyl group enhances the biological activity and metabolic stability of the resulting compounds, making it valuable in the development of drugs targeting specific diseases. It is often employed in the creation of small molecule inhibitors that interact with enzymes or receptors, particularly in the treatment of cancer, inflammation, and neurological disorders. Additionally, its unique structure allows it to serve as a building block for the design of novel therapeutic molecules with improved efficacy and selectivity.